News
During the presentation, Dr. Beetham will discuss the Company's progress in advancing its gene-editing technology platform, recent regulatory developments supporting agricultural innovation, and Cibus ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...
Ghana, an environment biotechnology-driven organisation, has launched the 2025 edition of OFAB Media Awards (OMA), and called for entries from journalists reporting on agricultural biotechnologies ...
The agribusiness ties are complementary and mutually beneficial. Brazil contributes to China's food security by supplying grains for animal feed, supporting the country's rising demand for protein.
The field of candidates running to become the next governor of Ohio has narrowed, as current Attorney General Dave Yost, an early entrant in the race, announced Friday, May 16, that he is suspending ...
On the Move and After Hours: Buchanan; Fox Rothschild; Spiro Harrison; The Nabulsi Family Foundation
Buchanan Ingersoll & Rooney continues its expansion with the addition of Lucas W. Morgan as a shareholder in its FDA & ...
Learn more about whether BioCryst Pharmaceuticals, Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ ...
Biowave will address this lackluster entrepreneurial activity and bring more VC investment into India’s life sciences.
The company has increased manufacturing capacity from pilot scale to 1 million liters annually, and can now assist customers ...
Dr Krishna Ella, Founder, Biovet, and Executive Chairman of Bharat Biotech said that Biolumpivaxin is a novel indigenous live ...
N Chandrababu Naidu launches BIOLUMPIVAXIN, world's first DIVA market vaccine for LSD, offering relief to cattle farmers.
GSK will acquire a liver-disease treatment from Boston Pharmaceuticals for up to $2 billion as it seeks to boost its pipeline of new drugs. The British pharma giant said Wednesday that it will pay the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results